Studies have shown that in bladder cancer, activation of this pathway is mainly associated with the loss of PTEN (phosphatase and tensin homolog) or PIK3CA gene mutations (Table 1), and is more common in high-grade bladder cancer. Here, PTEN is linked to urinary bladder carcinoma.